Successes and failures in human tuberculosis vaccine development.

about

Prophylactic Sublingual Immunization with Mycobacterium tuberculosis Subunit Vaccine Incorporating the Natural Killer T Cell Agonist Alpha-Galactosylceramide Enhances Protective Immunity to Limit Pulmonary and Extra-Pulmonary Bacterial Burden in Mic

P2860

Q47324477-3D16A10F-049C-494A-9C66-B8BFCDF8E3AE

P2860

Successes and failures in human tuberculosis vaccine development.

Item

http://www.wikidata.org/entity/Q41996442

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Successes and failures in human tuberculosis vaccine development.

@en

type

Item

label

Successes and failures in human tuberculosis vaccine development.

@en

prefLabel

Successes and failures in human tuberculosis vaccine development.

@en

P1476

Successes and failures in human tuberculosis vaccine development

@en

P2093

Roberto Zenteno-Cuevas

http://www.w3.org/2001/XMLSchema#string

P2860

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

Lessons learned in the analysis of high-dimensional data in vaccinomics

Tuberculosis vaccines and prevention of infection

Emerging Vaccine Technologies

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments

Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Evaluation of new vaccines for tuberculosis in the guinea pig model.

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.

P304

1481-1491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2017.1378641

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

R Zenteno-Cuevas

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28927311

http://www.w3.org/2001/XMLSchema#string

Successes and failures in human tuberculosis vaccine development.

about

P2860

P2860

Successes and failures in human tuberculosis vaccine development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698